Diabetic Medicine logo Blackwell Publishing logo

Publisher: Blackwell Publishing

Volume 24, Number 5, May 2007
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

International Diabetes Federation: a consensus on Type 2 diabetes prevention
pp. 451-463(13)
Authors: Alberti, K. G. M. M.; Zimmet, P.; Shaw, J.

Clinical and cost-effectiveness of primary prevention of Type 2 diabetes in a `real world' routine healthcare setting: model based on the KORA Survey 2000
pp. 473-480(8)
Authors: Icks, A.; Rathmann, W.; Haastert, B.; Gandjour, A.; Holle, R.; John, J.; Giani, G.

Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia
pp. 481-485(5)
Authors: Spelman, L. M.; Walsh, P. I.; Sharifi, N.; Collins, P.; Thakore, J. H.

Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis
pp. 486-493(8)
Authors: Jennings, D. L.; Kalus, J. S.; Coleman, C. I.; Manierski, C.; Yee, J.

Introducing estimated glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin
pp. 494-497(4)
Authors: Warren, R. E.; Strachan, M. W. J.; Wild, S.; McKnight, J. A.

Genetic variation in thioredoxin interacting protein (TXNIP) is associated with hypertriglyceridaemia and blood pressure in diabetes mellitus
pp. 498-504(7)
Authors: van Greevenbroek, M. M. J.; Vermeulen, V. M. M-J.; Feskens, E. J. M.; Evelo, C. T.; Kruijshoop, M.; Hoebee, B.; van der Kallen, C. J. H.; de Bruin, T. W. A.

Achievement of metabolic targets for diabetes by English primary care practices under a new system of incentives
pp. 505-511(7)
Authors: Gulliford, M. C.; Ashworth, M.; Robotham, D.; Mohiddin, A.

Association of immune mediators at diagnosis of Type 1 diabetes with later clinical remission
pp. 512-520(9)
Authors: Schloot, N. C.; Hanifi-Moghaddam, P.; Aabenhus-Andersen, N.; Alizadeh, B. Z.; Saha, M. T.; Knip, M.; Devendra, D.; Wilkin, T.; Bonifacio, E.; Roep, B. O.; Kolb, H.

GAD65 autoantibody epitopes in adult patients with latent autoimmune diabetes following GAD65 vaccination
pp. 521-526(6)
Authors: Bekris, L. M.; Jensen, R. A.; Lagerquist, E.; Hall, T. R.; Agardh, C.-D.; Cilio, C. M.; Lethagen, Å. L.; Lernmark, Å.; Robertson, J. A.; Hampe, C. S.

Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations
pp. 527-532(6)
Authors: Wentholt, I. M. E.; Maran, A.; Masurel, N.; Heine, R. J.; Hoekstra, J. B. L.; DeVries, J. H.

Assessment of an empowerment education programme. A randomized study in teenagers with diabetes
pp. 550-556(7)
Authors: Viklund, G.; Örtqvist, E.; Wikblad, K.

Patient and professional accuracy of recalled treatment decisions in out-patient consultations
pp. 557-560(4)
Authors: Skinner, T. C.; Barnard, K.; Cradock, S.; Parkin, T.

Perinatal risk factors for childhood Type 1 diabetes in Western Australia—a population-based study (1980-2002)
pp. 564-570(7)
Authors: Haynes, A.; Bower, C.; Bulsara, M. K.; Finn, J.; Jones, T. W.; Davis, E. A.

Is the concept of `cardiometabolic risk' more useful than `metabolic syndrome'?
pp. 571-571(1)
Authors: Koshiyama, H.; Taniguchi, A.; Inagaki, N.; Seino, Y.

Time to move from serum creatinine to eGFR
pp. 571-571(1)
Authors: Bilo, H. J. G.; Logtenberg, S. J. J.; de Grauw, W. J. C.; Kleefstra, N.; Wolffenbuttel, B. H. R.

Authors' response
pp. 572-573(2)
Authors: New, J. P.; O'Donoghue, D. J.; Middleton, R. J.; Rudenski, A.; Dasgupta, I.; Marshall, S. M.

Diary dates
pp. 574-574(1)

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A